OpenEvidence

Private

Boston-based clinical decision support AI platform. Trains OpenEvidence Search on the full PubMed + medical literature corpus (35M+ papers) for physician question-answering at the point of care. Used by 250,000+ US physicians daily; partnerships with Elsevier and NEJM. Founded 2022.

Founders Daniel Nadler

CEO Daniel Nadler

Company

Founded

2022

Headquarters

Boston, United States

Financials

Total Funding

$225M

Sectors

Artificial Intelligence SaaS Healthtech

www.openevidence.com

Funding History

2 rounds

Series B Aug 23, 2026

$150M

Sequoia Capital (Lead) Kleiner Perkins Conviction Partners Elad Gil Elsevier Ventures NVIDIA GV (Google Ventures)

Series A Jul 15, 2024

$75M

Sequoia Capital (Lead) Kleiner Perkins Conviction Partners Elad Gil SV Angel

Funding data is compiled from multiple independent sources including company announcements, press coverage, and regulatory filings. While we strive for accuracy, amounts and dates may reflect reported figures at time of announcement.